Latest News

  • All
  • Insights
  • Interviews
  • News
  • Newsletter
  • Reports
More

    Editor's Picks

    • All
    • Insights
    • Interviews
    • News
    • Newsletter
    • Reports
    More

      Reports

      • All
      • Insights
      • Interviews
      • News
      • Newsletter
      • Reports
      More
        Load More

        Must Read

        • All
        • Insights
        • Interviews
        • News
        • Newsletter
        • Reports
        More

          Quick Takeaways:  Why It Matters?  Viyash is using BioForLife as a front-end platform to scale its companion animal business in Europe, starting with Italy, one of the continent’s largest and fastest-growing pet health markets.  Market-wise, the all-cash ₹188 crore deal gives Alivira immediate access to BioForLife’s established Italian pet-care franchise in nutraceuticals, pharmaceuticals, and rapid diagnostics, while creating two-way synergies: launching Alivira pipeline...